BioNTech SE (NASDAQ:BNTX), a biotechnology company renowned for its mRNA technology platform and COVID-19 vaccine success, is navigating a crucial phase in its evolution. With a market capitalization ...

This groundbreaking development may enable treatments for inflammatory diseases such as Crohn's and colitis.Researchers at ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw some participants achieving an 88.94% reduction in viral load.

But election vote tallies don't tell the whole story. Trump 2.0 is a manifestation of monumental changes in American ...

It was a busy week for the biotech sector, with regulatory and pipeline updates. Sage Therapeutics SAGE was in focus after it ...

After contending with another year of high food and labor costs, financially stressed consumers, and fierce competition, U.S. restaurant operators are approaching 2025 with a focus on engaging more ...

We connect food and pleasure when it comes to certain flavors, but you may not know that some foods partner with chemical ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...